Showing results (191-200 of 291) with videos related to
Sort By:
Pageof 30
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 2, 2005
Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameterKenji Ikeda, Masahiro Kobayashi, Satoshi Saitoh, et al.Journal of Clinical Microbiology|June 21, 2013
Prediction of treatment efficacy and telaprevir-resistant variants after triple therapy in patients infected with hepatitis C virus genotype 1Norio Akuta, Fumitaka Suzuki, Taito Fukushima, et al.Gut and Liver|September 28, 2013
What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot StudyYusuke Kawamura, Kenji Ikeda, Taito Fukushima, et al.Oncology|February 23, 2016
Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular CarcinomaHideo Kunimoto, Kenji Ikeda, Yushi Sorin, et al.Clinical Therapeutics|April 2, 2017
Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in JapanAkihiro Nishie, Satoshi Goshima, Hiroki Haradome, et al.Journal of Gastroenterology|March 2, 2022
The useful predictors of zinc deficiency for the management of chronic liver diseaseSoichi Iritani, Yusuke Kawamura, Nozomu Muraishi, et al.Journal of Gastroenterology|August 5, 2003
Clinical features of hepatitis B virus genotype A in Japanese patientsMariko Kobayashi, Yasuji Arase, Kenji Ikeda, et al.Oncology|November 17, 2021
Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis StageNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.Journal of Gastroenterology|November 27, 2004
Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001Mariko Kobayashi, Fumitaka Suzuki, Yasuji Arase, et al.Internal Medicine (Tokyo, Japan)|April 3, 2018
A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body MyositisToru Kuwano, Norio Akuta, Fumitaka Suzuki, et al.Pageof 30